Lantheus Holdings, Inc. (LNTH)

NASDAQ: LNTH · Real-Time Price · USD

99.53

+0.02 (0.02%)

Sep 30, 2026, 4:00 PM EDT - Market closed

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
PYLARIFY Revenue	962.11M	989.12M	1.06B
Other Radiopharmaceutical Oncology Revenue	-	-	384.00K
Total Radiopharmaceutical Oncology Revenue	962.11M	989.12M	1.06B
DEFINITY Revenue	340.00M	330.25M	317.79M
Neuraceq Revenue	126.50M	51.45M	-
TechneLite Revenue	-	86.80M	95.49M
Other Precision Diagnostics Revenue	-	24.62M	24.23M
Total Precision Diagnostics Revenue	520.90M	493.11M	437.51M
Strategic Partnerships and Other Revenue	73.30M	59.38M	38.18M
Revenue (Total)	1.56B	1.54B	1.53B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Product Revenue	1.51B	1.51B	1.52B
License and Royalty Revenue	43.42M	34.04M	9.13M
Revenue (Total)	1.56B	1.54B	1.53B